Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 3,504	$ 2,064	$ 5,885	$ 3,310
General and administrative	3,675	986	7,439	2,103
Total operating expenses	7,179	3,050	13,324	5,413
Loss from operations	(7,179)	(3,050)	(13,324)	(5,413)
Net loss	(7,179)	(3,050)	(13,324)	(5,413)
Net loss attributable to common stockholders (Note 10)	$ (7,179)	$ (3,765)	$ (13,324)	$ (6,834)
Net loss per share attributable to common stockholders - basic	$ (0.38)	$ (1.00)	$ (0.71)	$ (1.82)
Net loss per share attributable to common stockholders - diluted	$ (0.38)	$ (1.00)	$ (0.71)	$ (1.82)
Weighted-average number of shares used in computing net loss per common share, basic	18,828,680	3,764,488	18,814,691	3,764,488
Weighted-average number of shares used in computing net loss per common share, diluted	18,828,680	3,764,488	18,814,691	3,764,488